2012

Peptide Conference 2011The Peptide Conference 2011 papers are now available in digital format produced through Yudu.com.
To find out how to subscribe at £249.00 for 13 top-quality presentations, simply click here

Following the success of the second Peptide Conference, held earlier this year, we are delighted to announce that the third Peptide Conference will take place at Chilford Hall Conference Centre, Cambridge, UK from Tuesday, April 17 to Wednesday, April 18, 2012.

The Peptide Conference will take place in conjunction with our new Dynamic Outsourcing for Life Sciences (DOLS) event, which will add extra value to your participation.

The programme will feature papers from industry and academe describing new work in the areas of peptides as analytical tools, diagnostics and therapeutics, with an emphasis on practical applications of technologies for peptide drug and diagnostics discovery and development.

Papers confirmed to date are as follows:

Lead finding for peptide therapeutics
Dr Thomas Vorherr – Director Peptide Discovery, Novartis Pharma

A new approach for liquid phase peptide synthesis
Dr Daisuke Takahashi – Section Chief, Synthesis Group, Research Institute for Bioscience Products and Fine Chemicals, Ajinomoto Co, Inc

New technology for solid phase peptide synthesis
Dr Don Wellings – CEO, SpheriTech Ltd

Manufacturing of peptide APIs: latest developments in chemistry and technology
Dr Ralph Schoenleber – Director Biochemicals and Process Research, Bachem AG

New technologies for peptide manufacturing
Dr Michel Renard – Lonza Braine

Enhanced tools for the discovery, development and manufacture of peptides and proteins
Dr David Moody – CEO, TechnoPep Ltd

Absence of amplification role of the protein KLH on antibody response generated by a MAP Staphyloccocus aureus enterotoxin A (SEA) peptide compared with the corresponding monomeric peptide
Dr Vincent Le Moigne – Université de Bretagne Occidentale (University of Western Brittany)

Aggregation of peptides and small proteins: implications for product development
Professor Tudor Arvinte – School of Pharmacy, Department of Pharmaceutics and Biopharmaceutics, University of Geneva and Co-founder, Therapeomic Biotechnology Inc

New developments in cell-penetrating peptide conjugates of oligonucleotides
Dr Michael Gait – MRC Programme Leader, University of Cambridge

Flax cyclic peptides: profiling, isolation, characterisation and plausible applications
Dr Martin Reaney – Department of Plant Sciences, University of Saskatchewan

Flax peptides as an analytical tool
Pramodkumar Jadhav, MSc – Department of Food and Bioproduct Sciences, University of Saskatchewan

Enhanced peptide therapeutics through polymer conjugation
Dr John Burt – CEO, PolyTherics Ltd

Innovation in process technology for high-quality and cost-effective peptide manufacturing
Dr Mimoun Ayoub – Vice President Strategic Development, Peptisyntha

Biomimetic screening of class B G protein-coupled receptors
Dr Felix Hausch – Research Group Leader, Chemical Genomics, Max Planck Institute of Psychiatry

Carbon-14 labelled peptides: solid phase peptide synthesis, biotinylation and PEGylation
Dr Sean Kitson – Isotope Chemistry Laboratories, Almac

Delegates who will benefit from attending the conference are senior R&D scientists, managers and decision makers from pharmaceutical and biotechnology companies looking to develop new peptide analytics, therapeutics and diagnostics and efficiently and economically manufacture new peptide products.

To register Click Here

To submit a paper for The Peptide Conference 2012 or for further information on attending the conference as a delegate contact Tom Mulligan, Conference Director, avakado media.
Tel: +44 (0)1403 220755
Email: tom@avakado.eu
Web: www.avakado.eu

You can exhibit alongside the conference with a low-cost tabletop at a price of £1250 which includes two free registrations for the events (The Peptide Conference and DOLS).

Companies confirmed as presenters or exhibitors at the joint Peptide Conference/Dynamic Outsourcing for Life Sciences exhibition to date include Sandoz, Aptuit, ChiralQuest, DSM Pharma Chemicals, Agfa-Labs, Key Organics, Peptisyntha, PolyPeptide Laboratories, Almac, Strem Chemicals UK Ltd, Biotage Ltd, Endeavour Speciality Chemicals and Butterworth Laboratories.

To view the exhibition floorplan click here. To book your tabletop, select a stand number from the floorplan by clicking here and email your choice to mark@avakado.eu For further information on exhibiting contact Mark Harrington, avakado media, Tel: +44-(0)1403-220753 Email: mark@avakado.eu